Navigation Links
Nanomedical Diagnostics Issued Key Patent for AGILE R100, a Graphene Biosensor for Drug Discovery
Date:5/9/2017

The United States Patent and Trademark Office has issued U.S. Patent No. 9,618,476 to Nanomedical Diagnostics, a biotech company pioneering label-free graphene biosensors for use in drug discovery. The patent covers any holistic graphene biosensor system that detects biomolecular interactions and is a foundational patent behind the company’s AGILE R100 platform.

“This patent showcases our company commitment to bringing cutting-edge nanotechnology to the life science world,” says Nanomedical Diagnostics founder and CTO, Dr. Brett Goldsmith, also the inventor named on the patent. “Graphene biosensors solve many problems encountered with current sensing tools and enable capabilities that aren’t possible with existing techniques. We are committed to developing graphene biosensors into sensitive measurement tools that help biomedical researchers make confident decisions earlier. The issuance of this patent demonstrates that.”

The patent issue highlights the achievement of the Nanomedical Diagnostics technology team in developing a novel approach for label-free detection of biomolecular interactions. The ability to leverage graphene biosensors in a user-friendly, complete system enables sensitivity, small sample sizes, portability, and ease of use that open new applications in the fields of drug discovery, disease diagnostics, health monitoring, and biomanufacturing.

AGILE R100 is available for commercial sale, for research use only.

Read the full story at http://www.prweb.com/releases/Nanomedical_Diagnostics/Patent_issued/prweb14317265.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Nanomedical Diagnostics VP Production to Speak at Materials Research Society Spring Meeting
2. Nanomedical Diagnostics Announces Partnership with Rogue Valley Microdevices, Delivering World’s First Successful High-Volume Manufacturing for Graphene Biosensors
3. Nanomedical Diagnostics to Present Field Effect Biosensing for Fragment-Based Drug Discovery at SLAS 2017
4. Nanomedical Diagnostics CEO and CTO to Introduce Electronic Label-Free Assay Based on Field Effect Biosensing Technology at IDTechEx Show
5. Nanomedical Diagnostics launches a new graphene biosensor with unprecedented functionality for small molecule and protein analysis
6. Nanomedical Diagnostics Announces Scientific Advisory Board of Top Scientists and Medical Researchers
7. ClearLight Diagnostics and Researchers at the Indiana Universitys Melvin and Bren Simon Cancer Center Announce a Collaboration to Profile the Tumor Microenvironment in Patients with Breast Cancer
8. Molecular or Immunoassay? Which Technology Will Win the Race for the Point of Care Diagnostics Market?
9. EU Adopts New Diagnostics and Medical Device Regulations, USDM Life Sciences Helps Organizations Comply
10. Personal Genome Diagnostics Announces AACR Annual Meeting 2017 Presentations and Awards
11. Personal Genome Diagnostics Announces Expanded Cancer Testing Contract with U.S. Department of Veteran Affairs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... , ... AMRI, a global contract research, development and manufacturing ... and quality of life, will now be offering its impurity solutions as a ... requirements for all new drug products, including the finalization of ICH M7 earlier ...
(Date:10/11/2017)... ... October 11, 2017 , ... At its national board meeting ... I. Sheikh, the co-founder, CEO and chief research scientist of Minnesota-based Advanced Space ... membership in ARCS Alumni Hall of Fame . ASTER Labs is a ...
(Date:10/11/2017)... ... 11, 2017 , ... Personal eye wash is a basic first aid supply for any work ... which eye do you rinse first if a dangerous substance enters both eyes? It’s one ... with its unique dual eye piece. , “Whether its dirt and debris, or an ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... will be hosting a Webinar titled, “Pathology is going digital. Is your lab ... digital pathology adoption best practices and how Proscia improves lab economics and realizes ...
Breaking Biology Technology:
(Date:4/11/2017)... 11, 2017 NXT-ID, Inc. (NASDAQ:   ... announces the appointment of independent Directors Mr. Robin D. ... Board of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , ... forward to their guidance and benefiting from their considerable expertise ...
(Date:4/5/2017)... 2017 Today HYPR Corp. , leading ... component of the HYPR platform is officially FIDO® ... security architecture that empowers biometric authentication across Fortune 500 ... secured over 15 million users across the financial services ... home product suites and physical access represent a growing ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
Breaking Biology News(10 mins):